XML 109 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings per Share
12 Months Ended
Dec. 31, 2013
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
Basic and diluted earnings per share are calculated as follows:
 
For the Years Ended December 31,
(In millions)
2013
 
2012
 
2011
Numerator:
 
 
 
 
 
Net income attributable to Biogen Idec Inc.
$
1,862.3

 
$
1,380.0

 
$
1,234.4

Adjustment for net income allocable to preferred stock

 

 
(0.5
)
Net income used in calculating basic and diluted earnings per share
$
1,862.3

 
$
1,380.0

 
$
1,233.9

Denominator:
 
 
 
 
 
Weighted average number of common shares outstanding
236.9

 
237.9

 
242.4

Effect of dilutive securities:
 
 
 
 
 
Stock options and employee stock purchase plan
0.3

 
0.5

 
1.0

Time-vested restricted stock units
0.8

 
1.0

 
1.3

Market stock units
0.3

 
0.3

 
0.3

Dilutive potential common shares
1.4

 
1.8

 
2.6

Shares used in calculating diluted earnings per share
238.3

 
239.7

 
245.0


Amounts excluded from the calculation of net income per diluted share because their effects were anti-dilutive were insignificant.
Earnings per share for the years ended December 31, 2013, 2012 and 2011, reflects, on a weighted average basis, the repurchase of 0.9 million shares, 5.8 million shares and 6.0 million shares, respectively, of our common stock under our share repurchase authorizations.